These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21033227)

  • 1. Gastric emptying and electrogastrography in reflux esophagitis: results in patients showing endoscopically erosive esophagitis under proton pump inhibitor therapy.
    Kudara N; Chiba T; Suzuki K
    Hepatogastroenterology; 2010; 57(101):772-6. PubMed ID: 21033227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis.
    Nakamura H; Nakaji G; Shimazu H; Yasuda S; Odashiro K; Maruyama T; Kaji Y; Chishaki A
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):270-6. PubMed ID: 17665548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement and comparison of gastric emptying and esophageal manometry in patients with reflux esophagitis.
    Shibata H; Harasawa S; Miwa T
    Tokai J Exp Clin Med; 1985 Dec; 10(6):631-6. PubMed ID: 3837953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric emptying in patients with severe reflux esophagitis.
    Keshavarzian A; Bushnell DL; Sontag S; Yegelwel EJ; Smid K
    Am J Gastroenterol; 1991 Jun; 86(6):738-42. PubMed ID: 2038997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide.
    Behar J; Ramsby G
    Gastroenterology; 1978 Feb; 74(2 Pt 1):253-6. PubMed ID: 620898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of esophageal sphincter tonus and of gastric motility in the extent of reflux esophagitis].
    Cogliandolo A; Gulino FM; Pustorino S; Migliorato D; Bottari M; Saitta FP; Micali B
    Minerva Chir; 1992 Jan; 47(1-2):11-7. PubMed ID: 1553047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multi-channel electrogastrography and autonomic nervous system function in patients with non-erosive reflux disease and reflux esophagitis].
    Ding ZL; Xu XH; Wang ZF; Ke MY
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):263-5. PubMed ID: 19552845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexlansoprazole (Kapidex) for GERD and erosive esophagitis.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):21-2. PubMed ID: 19305367
    [No Abstract]   [Full Text] [Related]  

  • 11. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastric emptying in reflux esophagitis. Effect of metoclopramide and cinitapride].
    Monés J; Espinós JC; Carrió I; Calabuig R; Vilardell F
    Med Clin (Barc); 1989 Sep; 93(9):331-4. PubMed ID: 2691780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for erosive reflux esophagitis: a case-control study.
    Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
    Am J Gastroenterol; 2001 Jan; 96(1):41-6. PubMed ID: 11197285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
    Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
    Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics.
    Fass R
    J Clin Gastroenterol; 2007 Feb; 41(2):131-7. PubMed ID: 17245209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.
    Hoffman I; Tertychnyy A; Ectors N; De Greef T; Haesendonck N; Tack J
    J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.